Skip to main content
. 2016 Aug 19;11(4):254–258. doi: 10.1159/000447765

Table 1.

Features of indicators for benign and malignant breast masses

Indicatorsa Benign lesions (n = 23) Malignant lesions (n = 31) p values
DCE-MRI
 IER, % 167.98 ± 45.56 230.09 ± 34.50 < 0.001
 TIC, n (%) < 0.001
  Type I 18 (78.26) 3 (9.68) < 0.001
  Type II 4 (17.39) 6 (19.35) 0.854
  Type III 1 (4.35) 22 (70.97) < 0.001
DW-MRI
 ADC0,1000 ≤ 1.09 (× 10-3 mm2/s) 1.22 ± 0.20 1.03 ± 0.14 < 0.001
 ADC50,800 ≤ 1.10 (× 10-3 mm2/s) 1.24 ± 0.21 1.04 ± 0.15 < 0.001
IVIM
 D (× 10-3 mm2/s) 1.32 ± 0.15 0.91 ± 0.15 < 0.001
 D* (× 10-3 mm2/s) 45.46 ± 25.25 26.54 ± 21.91 0.005
 f, % 15.16 ± 9.90 21.18 ± 7.84 0.016
a

Unless otherwise indicated, continuous data are presented as the mean ± standard deviation.

DCE-MRI = Dynamic contrast-enhanced magnetic resonance imaging; IER = initial enhancement ratio; TIC = time-signal intensity curve; DW-MRI = diffusion-weighted magnetic resonance imaging; ADC = apparent diffusion coefficient; IVIM = intravoxel incoherent motion; D = tissue diffusivity;

*

D* = pseudodiffusivity; f= perfusion fraction.